Earnings Feed
Start Free
$REGN·4

REGENERON PHARMACEUTICALS INC · Dec 18, 4:27 PM ET

REGENERON PHARMACEUTICALS INC 4

4 · REGENERON PHARMACEUTICALS INC · Filed Dec 18, 2015

Insider Transaction Report

Form 4
Period: 2015-12-16
REGENERON PHARMACEUTICALS INCREGN
Powchik Peter
SVP Clinical Development
Transactions
  • Exercise/Conversion

    Common Stock

    2015-12-16$52.03/sh+1,921$99,950→ 17,742 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2015-12-16+25,000→ 25,000 total
    Exercise: $555.67Exp: 2025-12-16→ Common Stock (25,000 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-12-16−1,921→ 0 total
    Exercise: $52.03Exp: 2021-12-16→ Common Stock (1,921 underlying)
Holdings

  • Common Stock

    (indirect: by GRAT)
    12,890

  • Common Stock

    (indirect: By 401(k))
    1,652
Footnotes (2)
  • [F1]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  • [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT